N1BI34

Neurocrine Biosciences, Inc.

BR Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
39.480000
Fair value
34.205513
Expectation
Undecided 52.31%
Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 3 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
39.48
12-Week Change
18.13%
Trend Signal
Inactive
Expectation
Undecided 52.31%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-2.38
Market Dynamics
1.01

Over the latest 12 completed weeks ending 2026-05-29, N1BI34 rose 18.13%, moving from 33.42 to 39.48. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -2.38 and has improved across the 12-week window. Market Dynamics is 1.01 on the latest week. Expectation is undecided at 52.31%.